Top Markets
Coin of the day
Avivagen Inc. Avivagen Inc.

Avivagen Inc.

VIV
Clasificación en acciones #40244
Avivagen Inc. is a life sciences enterprise that invents and sells specialized... Avivagen Inc. is a life sciences enterprise that invents and sells specialized products, primarily for animal feed, aimed at bolstering the immune systems of livestock. These solutions are designed to enhance animals' health, leading to improved growth and overall productivity. The company's diverse product lineup features OxC-beta Livestock, a crucial premix for farm animal diets. Beyond agriculture, Avivagen also manufactures health supplements such as Vivamune and Dr. Tobias-branded chews for dogs, along with the Dr. Tobias Beta blend, formulated to support human immunity. Established in 2005 and based in Ottawa, Canada, Avivagen Inc. distributes its offerings across numerous international markets, including the United States, Canada, the Philippines, Taiwan, Thailand, China, Mexico, Brazil, and Malaysia.
Precio por acción
$0.00368316
Última sincronización: 2024-03-04
Capitalización bursátil
$199.43K
Cambio (1 día)
0.05%
Cambio (1 año)
0.00%
País
CA
Comercio Avivagen Inc. (VIV)

Categoría

Ganancias de Avivagen Inc. (VIV)
Ganancias en 2026 TTM: 0
Secondo gli ultimi rapporti finanziari di Avivagen Inc., gli utili attuali della società sono 0. Nel 2026, la società ha registrato un utile di 0, igual a agli utili del 2026, che erano di 0. Gli utili mostrati in questa pagina sono quelli prima degli interessi e delle imposte, ovvero EBIT.
Historial de ganancias de Avivagen Inc. desde 2026 hasta 2026
Ganancias al final de cada año
Año Ganancias Cambiar
Not enough data for the provided dates.
Ganancias de empresas similares o competidoras